Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-26-001170
Filing Date
2026-01-13
Accepted
2026-01-13 14:48:54
Documents
1
Period of Report
2026-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 9309
  Complete submission text file 0001437749-26-001170.txt   10854
Mailing Address C/O CLENE INC. 6550 SOUTH MILLROCK DR, SUITE G50 SALT LAKE CITY UT 84121
Business Address
MATLIN DAVID J (Reporting) CIK: 0001251956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 26529653

Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)